Investors

09: Development of annual general meeting

April 01 2009

Announcement 09

Development of Annual General Meeting

The Annual General Meeting was held in accordance with the published agenda (announcement dated March 18, 2009).

The General Meeting took note of the report on the Company’s activities and adopted the Annual Report 2008. Also, the General Meeting adopted the proposed decision on use of profit/loss.

All proposals from the Board of Directors in the agenda’s item 3 were carried unanimously, thus:

a.Amendment of the authorization of the Board of Directors to increase the company’s share capital, so as the authorization is prolonged to March 31, 2014 and the maximum capital increase is reduced to DKK 100 million. The amended authorization is inserted as article 15a substituting article 15a of the Company Articles;

b.Authorization of the Board of Directors to issue, on one or more occasions, a number of convertible instruments of debt with a principal of up to a total of DKK 50 million and a corresponding capital increase. The authorization is inserted as a new article 15b of the Company Articles;

All board members were up for election. Carsten Lønfeldt, Peter Nordkild and Niels T. Foged were re-elected and new candidate Marianne Weile Nonboe was elected. Ejner Bech Jensen did not seek re-election and has resigned from the Board as of this General Meeting. After the meeting the Board constituted itself with Carsten Lønfeldt as chairman.

Deloitte was re-elected auditor for BioPorto A/S

Gentofte, April 1, 2009

The Board of Directors

BioPorto A/S

For further information please contact:

Thea Olesen, CEO

Christina Tønnesen, Investor Relations

Tel. +45 4529 0000

e-mail: investor@bioporto.com